ResMed Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Valuation Ratios
P/E Ratio26.9627.5435.8039.3875.67
Forward P/E25.3222.8630.8234.1045.81
P/S Ratio7.346.007.618.5811.23
P/B Ratio6.335.787.789.1312.44
Price/Tangible Book15.3718.3039.8028.4663.52
Price/FCF22.7321.6056.02141.8856.63
Price/OCF21.5620.0746.3587.4048.73
PEG Ratio1.651.542.392.453.30
Enterprise Value Ratios
EV/Revenue7.326.207.968.7511.42
EV/EBITDA20.2418.9326.0227.8035.49
EV/EBIT22.3220.9729.1831.2439.80
EV/FCF22.6622.3058.60144.7157.60
Profitability & Returns
Return on Equity (ROE)0.26%0.23%0.24%0.25%0.18%
Return on Assets (ROA)0.14%0.13%0.12%0.13%0.12%
Return on Invested Capital (ROIC)0.25%0.20%0.20%0.22%0.15%
Return on Capital Employed (ROCE)0.24%0.23%0.19%0.23%0.24%
Leverage & Solvency Ratios
Debt/Equity0.140.180.380.270.28
Debt/EBITDA0.450.561.190.790.75
Debt/FCF0.510.672.754.241.25
Liquidity Ratios
Current Ratio3.442.593.122.801.73
Quick Ratio2.161.221.231.281.01
Efficiency Ratios
Asset Turnover0.680.690.710.730.69
Inventory Turnover2.091.871.842.302.97
Yield & Distribution Ratios
Earnings Yield0.04%0.04%0.03%0.03%0.01%
FCF Yield0.04%0.05%0.02%0.01%0.02%
Dividend Yield0.01%0.01%0.01%0.01%0.01%
Payout Ratio0.22%0.28%0.29%0.31%0.48%
Buyback Yield0.00%0.00%0.00%0.00%-0.01%
Total Return0.01%0.01%0.01%0.00%0.00%